Bremer Trust National Association’s Teva Pharmaceuticals TEVA Stock Holding History

Bremer Trust National Association’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$4K	Buy	+247	New	+$5.06K	﹤0.01%	716

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Bremer Trust National Association's TEVA Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2018: 247 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #716 among its holdings.

552 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

Bremer Trust National Association held 247 shares of Teva Pharmaceuticals worth $4K as of Q4 2018.
Teva Pharmaceuticals was a new Bremer Trust National Association position in Q4 2018.
Teva Pharmaceuticals made up ﹤0.01% of Bremer Trust National Association's portfolio in Q4 2018, its #716 holding.
552 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.